Replies to post #17066 on Marker Therapeutics Inc (MRKR)

[JeansOnFire]

I am expecting a new combo trial with roche to be announced in the next 6 months. Dont know if that is a near term catalyst though. And you never know what can be expected when talking about Polystart. Hopefully they will add that in to their trials soon.

Oh yeah almost forgot. More grant money could be coming also.

[lasers]

Jimjames welcome to the $TPIV MB and your first investments.

Best to read firstly in detail the info on the $TPIV website.

http://www.tapimmune.com/

[Rogerthat1]

Will answer a few for you.

Up list has been on the table since a while. Not much of a near term catalyst IMO unless RS

Data read out on P1 is speculation based on trial completion date on clinical trials site. Nothing official from co on timeline

Orphan designation news was PRed AH a day or two after the market already heard about it so some of the news was baked into the price when the news actually came out. You'll realize quickly TPIV is not the best when it comes to company communications and Pr but it is improving in that department for sure.

I wasn't around at the time of last RS so no perspective on that from my side.

Partnership news with AZN was also promised for a long time since early dec 2015. So most of it got baked into a small run to the 80s. And when the actual news came out, market expected some upfront payment whatnot which didn't happen (wasn't realistic IMO) and plus the actual PR was delayed so some folks sold off after news.

A lot of potential here but need to wait for things to happen. Might see a mini run or two between now and a rather important catalyst whichever that might be. All IMO.